
Experts highlight AI adoption, sustained-release glaucoma therapies, and concerns about Medicare payment and rural access.

Fiaz Zaman, MD, FACS, ophthalmologist, Houston Eye Associates.

Experts highlight AI adoption, sustained-release glaucoma therapies, and concerns about Medicare payment and rural access.

New 12-month phase 1/2 data show the BIM-IOL System lowered IOP and kept most patients drop-free after cataract surgery.